Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
2008
The Glutathione Status of Cells
1978
Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.
1996
High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity
2004
Ischemia and reperfusion—from mechanism to translation
2011 Standout
The immune system, amyloid‐β peptide, and Alzheimer's disease
2005
Nonlinear magic: multiphoton microscopy in the biosciences
2003 Standout
Probing the pressure–temperature stability of amyloid fibrils provides new insights into their molecular properties
2005
Modifying enzyme activity and selectivity by immobilization
2012 Standout
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
2003
Treatment Strategies Targeting Amyloid -Protein
2012
Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis
2002
Crystal Structure of HEL4, a Soluble, Refoldable Human VH Single Domain with a Germ-line Scaffold
2004 StandoutNobel
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Complement-Mediated Ischemia-Reperfusion Injury
2009
Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced Aβ Phagocytosis yet Lack Aβ-Activated Neurotoxicity
2005
Probing the origins, diagnosis and treatment of amyloid diseases using antibodies
2004
Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
2003
Immunotherapeutic Approaches for Alzheimer’s Disease
2015
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid
2006
Single‐domain antibody fragments with high conformational stability
2002
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque‐competence, Aβ(1–40)ox and Aβ(1–42)ox
2001 StandoutNobel
Inhibition of Amyloid Formation
2012
Protein aggregation and neurodegenerative disease
2004 Standout
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
2004 Standout
Role of Protein -SH Groups in Redox Homeostasis— The Erythrocyte as a Model System
1998
Neurovascular regulation in the normal brain and in Alzheimer's disease
2004 Standout
A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
2008
Immunology and immunotherapy of Alzheimer's disease
2006
Current progress in beta-amyloid immunotherapy
2004
Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease
2005
Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice
2001
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Alzheimer's disease
2006 Standout
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Alzheimer's Disease
2010 Standout
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
2002
Sterile inflammation: sensing and reacting to damage
2010 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force Microscopy
2003
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability
2002 Standout
Microglial EP2 as a New Target to Increase Amyloid β Phagocytosis and Decrease Amyloid β-Induced Damage to Neurons
2006
Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels
2012 Standout
Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's disease
2002
Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies
2001
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
2003 Standout
Solution structures of micelle-bound amyloid β-(1-40) and β-(1-42) peptides of Alzheimer’s disease 1 1Edited by P. E. Wright
1999
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
2008 Standout
Mannan binding lectin and its interaction with immunoglobulins in health and in disease
2006
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies
2004
The amyloid state and its association with protein misfolding diseases
2014 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Molecular Mechanisms of Amyloidosis
2003 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition
2004
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
2012
Active and Passive Immunotherapy for Neurodegenerative Disorders
2008
Oriented immobilization of proteins
1998
Conformational Abs recognizing a generic amyloid fibril epitope
2002
Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential
2001
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils
2007
Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
2008
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Localized Surface Plasmon Resonance Spectroscopy and Sensing
2006 Standout
Immunotherapy for Alzheimer's disease
2004
Advances in the design of new epoxy supports for enzyme immobilization–stabilization
2007
Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby Immunotherapy
2002
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
A water-soluble metal–organic complex array as a multinuclear heterometallic peptide amphiphile that shows unconventional anion dependency in its self-assembly
2015 StandoutNobel
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
2003
A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
2014
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Oxidized Redox State of Glutathione in the Endoplasmic Reticulum
1992 StandoutScience
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
2001 Standout
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
2003 StandoutScience
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Molecular basis for passive immunotherapy of Alzheimer's disease
2007
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Physiology of Microglia
2011 Standout
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Works of Rela Koppel being referenced
Enhanced activity of immobilized dimethylmaleic anhydride-protected poly- and monoclonal antibodies
1990
IgM detection via selective recognition by mannose-binding protein
2001
Localization of a highly immunogenic region of carboxypeptidase A recognized by three different monoclonal antibodies and their use in the detection of subtle conformational alterations in this enzyme region
1989
EFRH–Phage Immunization of Alzheimer's Disease Animal Model Improves Behavioral Performance in Morris Water Maze Trials
2004
Enzymic oxidation of monoclonal antibodies by soluble and immobilized bifunctional enzyme complexes
1990
Disaggregation of Alzheimer β-amyloid by site-directed mAb
1997
Highly active enzyme preparations immobilized via matrix-conjugated anti-Fc antibodies
1991
Sensitivity of Hemoglobin Thiol Groups within Red Blood Cells of Rat during Oxidation of Glutathione
1977